click here to download the absract project
click here to download the Base paper
ABSTRACT
The Covid-19 Corona virus, otherwise called SARS-CoV-2, has been killed from the world and things go severely. It is a pandemic that spreads to the world consistently. The current framework gives engine data in a cooperative manner to handily investigate and foresee the advancement of an issue in a specific locale. A perusing and composing machine (ML) can be utilized to adequately tackle an issue and its
activity. Perusing and composing machine controls (SMLMs) and calculations connected with backwardness and scientific composing assist with displaying preparing. The distance is more noteworthy than the quantity of direct articles. Inversion calculation(MDR). The worldwide informational index is gathered, prehandling, and the quantity of affirmed cases to a specific date vanishes. It assists with preparing a model for anticipating the quantity of legitimate cases around the world.
Keywords— Machine Literacy (ML), Supervised Machine Literacy Models (SMLM), Multiple direct retrogression (MDR)
INTRODUCTION
OUTLINE OF THE PROJECT:
As of September 6, 2021, COVID-19 has caused more than 219 million infections worldwide and resulted in more than 4.55 million deaths. Complications are more common among elderly patients and people with preexisting conditions, and the rate of intensive care unit (ICU) admission is substantially higher in these groups . ICU admissions rely on the critical care capacity of the health care system. Iran, which is
the primary test bed for this study, was one of the fifirst countries hit by COVID-19. The ICU admission rate involves about 32% of all hospitalizations, and the ICU mortality rate is about 39%. With the potential of new waves of COVID-19 infections driven by more transmissible variants, ICU hospitalization numbers are expected to rise, leading to shortages of ICU beds and critical management equipment. There is also the risk of a global shortage of effective medical supplies, making the judicious use of these medications a top priority for healthcare systems. An individual-based prediction model is essential for tailoring treatment strategies and would aid in expanding our insights into the pathogenesis of COVID-19. A number of risk assessment scores are available to predict the severity of different diseases in ICU patients. Predictors of the need for intensive respiratory or vasopressor support in patients with COVID-19 and of mortality in COVID-19 patients with pneumonia have been identified. To date, no general mortality prediction scores have been available for ICU admitted COVID-19 patients, irrespective of the patients’ clinical presentation. Additionally, existing risk scales rely on parameters measured by health care providers such as blood pressure, respiratory rate, and oxygen saturation, which are subject to human
error and operator bias especially under challenging and stressful conditions when numbers of COVID-19 patients surge. Thus, it remains vital to develop more unbiased risk-assessment tools that can predict the most likely outcomes for individual patients with COVID-19. Recent advances in artificial intelligence (AI)
technology for disease screening show promise as computer-aided diagnosis and prediction tools. In the era of COVID-19, AI has played an important role in early diagnosis of infection, contact tracing, and drug and vaccine development. Thus, AI represents a useful technology for the management of COVID-19 patients with the potential to help control the mortality rate of this disease. Nevertheless, an AI tool for making standardized and accurate predictions of outcomes in COVID-19 patients with severe disease is currently missing. Beyond the general benefits of data-driven decision-making, the pandemic has also exposed the need for computational assistance to health care providers, who under the pressure of
severely ill patients may make mistakes in judgment. Stressful conditions and burnout in health care providers can reduce their clinical performance, and a lack of accurate judgment can lead to increased mortality rates. Artificial intelligence can help healthcare professionals determine who needs a critical level of care more precisely. Indeed, the effective use of AI could mitigate the severity of this outbreak. Here, we propose a personalized machine-learning (ML) method for predicting mortality in COVID-19 patients based on routinely available laboratory and clinical data on the day of ICU admission.
